健帆生物：关于不向下修正健帆转债转股价格的公告

Core Viewpoint - The company has decided not to lower the conversion price of its convertible bonds, maintaining the current terms for the time being [2]. Summary by Relevant Sections - Company Decision: On September 12, 2025, the company held its 32nd meeting of the fifth board of directors, where it approved the proposal not to adjust the conversion price of the "Jianfan Convertible Bonds" downward [2]. - Future Conditions: The next period for recalculating the conditions for triggering a downward adjustment of the conversion price will start from the first trading day after September 12, 2025. If the conditions are triggered again, the company will follow the relevant procedures to decide whether to exercise the right to adjust the conversion price downward [2].